Activation of the innate immune system and alcoholic liver disease: Effects of ethanol per se or enhanced intestinal translocation of bacterial toxins induced by ethanol?

Alcoholism: Clinical and Experimental Research

Volumn 29, Issue 11 SUPPL., 2005, Pages

  Bode, Christiane ^a   Bode, J Christian ^b  

^a UNIVERSITY OF HOHENHEIM   (Germany)

^b Hohenheim University ^*

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BACTERIAL TOXIN; CD14 ANTIGEN; ENDOTOXIN; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE BINDING PROTEIN; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ALCOHOL OXIDATION; BACTERIAL GROWTH; CELL ACTIVATION; CELL INFILTRATION; CELL ISOLATION; CONFERENCE PAPER; CYTOKINE PRODUCTION; ENDOTOXEMIA; ENZYME ACTIVITY; HUMAN; INNATE IMMUNITY; INTESTINE MUCOSA; INTESTINE MUCOSA PERMEABILITY; KUPFFER CELL; LIVER INJURY; MACROPHAGE; MONOCYTE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN SECRETION; SMALL INTESTINE; STOMACH HEMORRHAGE;

ANIMALS; BACTERIAL TOXINS; ENDOTOXEMIA; ETHANOL; GASTROINTESTINAL TRACT; HUMANS; IMMUNITY, NATURAL; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; LIPOPOLYSACCHARIDES; LIVER; LIVER DISEASES, ALCOHOLIC; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 32044469602     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.alc.0000189280.19073.28     Document Type: Conference Paper

References (49)

1. Adachi Y, Moore LE, Bradford BU, Gao W, Thurman RG (1995) Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology 108:218-224.
2. Bird GL, Sheron N, Goka AK, Alexander GJ, Williams RS (1990) Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann Intern Med 112:917-920.
3. Bode C, Bode JC (2003) Effect of alcohol consumption on the gut. Best Practice & Research Clinical Gastroenterology Vol. 17, No 4:575-592.
4. Bode C, Fukui H, Bode JC (1993) "Hidden" endotoxin in plasma of patients with alcoholic liver disease. Eur J Gastroenterol Hepatol 5:257-262.
5. th International Congress on the Immune Consequences of Trauma, Shock and Sepsis Mechanisms and Therapeutic Approaches. Bologna: Monduzzi Editore, 247-252.
6. Bode JC (1999) Alcoholic liver disease. (Porro GB, Cremer M, Krejs G, Ramadori G, Rask-Madsne J, eds.) Gastroenterology and Hepatology. London: McGraw-Hill pp 511-522.
7. Bode JC (2002) Assessment of the Reversibility and Treatments of Alcoholic Liver Disease. in Molecular Biology and Immunology in Hepatology (Tsuji T, Higashi T, Zeniya M, Meyer zum Büschenfelde KH, eds). Elsevier Science B.V. 183-197.
8. Bode JC, Bode C, Heidelbach R, Dürr HK, Martini GA (1984) Jejunal microflora in patients with chronic alcohol abuse. Hepatogastroenterology 31:30-34.
9. Bode JC, Bode C, Kugler V (1982) Bacterial toxins and liver fibrosis. In Gerlach U, Pott G, Rauterberg J, Voss B, eds. Connective Tissues of the Normal and Fibrotic Human Liver. Stuttgart: Thieme pp 137-142.
10. Bode JC, Parlesak A, Bode C (2001) Gut derived bacterial toxins (endotoxin) and alcohol liver disease. Agarwal DP, Seitz HK, editors: Alcohol in Health and Disease. New York/Basel. Marcel Dekker: 369-386.
11. Deaciuc IV, D'Souza NB, Spitzer JJ (1995) Tumor necrosis factor-alpha cell-surface receptors of liver parenchymal and non-parenchymal cells during acute and chronic alcohol administration to rats. Alcohol Clin Exp Res 19:332-338.
12. Deviere J, Content J, Denys C, Vandenbussche P, Schandene L, Wybran J, Dupont E (1990) Excessive in vitro bacterial lipopolysaccharide-induced production of monokines in cirrhosis. Hepatology 11:628-634.
13. Diez-Ruiz A, Tilz GP, Gutierrez-Gea F, Gil-Extremera B, Murr C, Wachter H, Fuchs D (1995) Neopterin and soluble tumor necrosis factor receptor type I in alcohol-induced cirrhosis. Hepatology 21:976-978.
14. Feingold KR, Serio MK, Adi S, Moser AH, Grunfeld C (1989) Tumor necrosis factor stimulates hepatic lipid synthesis and secretion. Endocrinology 124:2336-2342.
15. Felver ME, Mezey E, McGuire M, Mitchell MC, Herlong HF, Veech GA, Veech RL (1990) Plasma tumor necrosis factor alpha predicts decreased long-term survival in severe alcoholic hepatitis. Alcohol Clin Exp Res 14:255-259.
16. Fukui H, Brauner B, Bode JC, Bode C (1991) Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay. J Hepatol 12:162-169.
17. Gregory SH, Wing EJ (2002) Neutrophil-Kupffer cell interaction: a critical component of host defenses to systemic bacterial infections. J Leukocyte Biol 72:239-248.
18. Grove J, Daly AK, Bassendine MF, Day CP (1997) Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis. Hepatology 26:143-146.
19. Hall P (1995) Pathological spectrum of alcoholic liver disease. Hall P, ed. Alcoholic Liver Disease. London: Arnold pp 41-68.
20. Hansen J, Cherwitz DL, Allen JI (1994) The role of tumor necrosis factor-alpha in acute endotoxin-induced hepatotoxycity in ethanol-fed rats. Hepatology 20:461-474.
21. Hill DB, McClain CJ, Barve ST (1998) Use of transfected liver cells to evaluate potential mechanisms of alcohol-induced liver injury. Alcohol Clin Exp Res 22:785-788.
22. Hines IN, Wheeler MD (2004) Recent Advances in Alcoholic Liver disease III. Role of the innate immune response in alcoholic hepatitis. Am J Physiol Gastrointest Liver Physiol. 2004 Aug; 287:G310-G314.
23. Iimuro Y, Gallucci RM, Luster MI, Kono H, Thurman RG (1997) Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat. Hepatology 26:1530-1537.
24. Janeway CA, Jr., Medzhitov R (2002) Innate immune recognition. Annu Rev Immunol 20:197-216.
25. Jarvelainen HA, Fang C, Ingelmann-Sundberg M, Lindros KO (1999) Effect of chronic coadministration of endotoxin and ethanol on rat liver pathology and pro-inflammatory and anti-inflammatory cytokines. Hepatology 29:1503-1510.
26. Jokelainen K (2001) Acetaldehyde and liver disease. Agarwal DP, Seitz HK, editors: Alcohol in Health and Disease. New York: Marcel Dekker:pp 387-406.
27. Khoruts A, Stahnke L, McClain CJ, Logan G, Allen JI (1991) Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology 13:267-276.
28. Kishore R, Hill JR, McCullen MR, Frenkel J, Nagy LE (2002) ERK1/2 and Egr-1 contribute to increased TNF-a production in rat Kupffer cells after chronic ethanol feeding. Am J Physiol Gastroitest Liver Physiol 282:G6-G15.
29. Kishore R, McCullen MR, Nagy LE (2001) Stabilization of Tumor Necrosis Factor a mRNA by Chronic Ethanol. J Biol Chem and Molecular Biology Vol 276, No 45:41930-41936.
30. Lieber CS (2000) Alcoholic liver disease: new insights in pathogenesis lead to new treatments. J Hepatol 32:113-128.
31. Lindros KO (1995) Alcoholic liver disease: pathobiological aspects. J Hepatol 23:7-15.
32. Mathurin P, Deng QG, Keshavarzian A et al (2000) Exacerbation of alcoholic liver injury by enteral endotoxin in rats. Hepatology 32:1008-1017.
33. McClain CJ, Barve S, Deaciuc I, Kugelmas M, Hill D (1999) Cytokines in alcoholic liver disease. Semin Liver Dis 19:205-219.
34. McClain CJ, Cohen DA (1989) Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology 9:349-351.
35. McClain CJ, Hill DB, Song Z, Deaciuc I, Barve S (2002) Monocyte activation in alcoholic liver disease. Alcohol 27:53-61.
36. Muzes G, Deak G, Lang I, Gonzales-Cabello R, Gergely P, Feher J (1989) Depressed monocyte production of interleukin-1 and tumor necrosis factor-alpha in patients with alcoholic liver cirrhosis. Liver 9:302-306.
37. Nagy LE (2003) Recent Insights into the Role of the Innate Immune System in the Development of Alcoholic Liver Disease. Ethanol and the Innate Immune System. Exp Biol Med 228:882-890.
38. Nanji AA, Khettry U, Sadrzadeh SM (1994) Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver disease. Proc Soc Exp Biol Med 205:243-247.
39. Nanji AA, Khettry U, Sadrzadeh SM, Yamanaka T (1993) Severity of liver injury in experimental alcoholic liver disease. Correlation with plasma endotoxin, prostaglandin E2, leukotriene B4, and thromboxane B2. Am J Pathol 142:367-373.
40. Parlesak A (2005) Alcohol, Altered Gut Permeability, and Endotoxins. Comprehensive Handbook of Alcohol Related Pathology Vol 2:965-975.
41. Schäfer C, Greiner B, Landig J, Feil E, Schütz ET, Bode JC, Bode C (1997) Decreased endotoxin-binding capacity of whole blood in patients with alcoholic liver disease. J Hepatol 26:567-573.
42. Schäfer C, Parlesak A, Carroll SF, Bode JC, Bode C (1996) Endotoxin plasma levels and endotoxin binding factors in patients with alcoholic liver disease. Alcohol Clin Exp Res 20:127.
43. Schäfer C, Schips I, Landig J, Bode JC, Bode C (1995) Tumor-necrosis-factor and interleukin-6 response of peripheral blood monocytes to low concentration of lipopolysaccharide in patients with alcoholic liver disease. Z Gastroenterol 33:503-508.
44. Sweet MJ, Hume DA (1996) Endotoxin signal transduction in macrophages. J Leukocyte Biol 60:8-26.
45. Szabo G (1999) Consequences of Alcohol Consumption on Host Defence. Alcohol Alcohol 34:830-841.
46. Thurman RG (1998) Mechanisms of hepatic toxicity. II Alcoholic liver injury involves activation of Kupffer cells by endotoxin. Am J Physiol 275:G605-G611.
47. Tilg H, Wilmer A, Vogel W, Herold M, Nolchen B, Judmaier G, Huber C (1992) Serum levels of cytokines in chronic liver diseases. Gastroenterology 103:264-274.
48. Yin M, Wheeler MD, Kono H, Bradford BU, Gallucci RM, Luster MI, Thurman RG (1999) Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice. Gastroenterology 117:942-952.
49. You MS (2001) Effect of endotoxin on liver cells-studies in primary liver cell cultures and its role in liver transplantation. Doctoral Thesis (PhD Thesis), Hohenheim University, Stuttgart.